UCP1 and obesity due to melanocortin 4 receptor deficiency: Subsequently, several well-designed studies have shown that metformin may prevent weight gain in preclinical models of obesity by increasing the metabolic activity of BAT in a manner that is dependent and independent of the distinct action of UCP1, which is a molecular marker able to dissipate chemically bound energy as heat [31,32,33,34].